Caixin
May 03, 2023 08:00 AM

Guangdong Marubi Biotechnology Co.,Ltd.’s Net Profit Dropped 30.6% in 2022

00:00
00:00/00:00
Listen to this article 1x

Guangdong Marubi Biotechnology Co.,Ltd. (广东丸美生物技术股份有限公司) (603983.SH) reported a net profit of 167.4 million yuan in 2022, down 30.6% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, down 3.1% year-on-year.

At the end of the reporting period, it had 4.1 billion yuan in total assets and 838.6 million yuan in total liabilities, with a liability-to-asset ratio of 20.5%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST